Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
2022 · Research and Practice in Thrombosis and Haemostasis · 11 citations
https://doi.org/10.1002/rth2.12736
F
Francisco Galeano‐Valle
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
135
Papers
1.6K
Citations
17
h-index
33
i10-index
Francisco Galeano‐Valle is an academic researcher from Universidad Complutense de Madrid. The author has contributed to research in topics: Venous Thromboembolism Diagnosis and Management & Atrial Fibrillation Management and Outcomes & Diagnosis and Treatment of Venous Diseases. The author has an h-index of 17, co-authored 115 publications.
ORCID: 0000-0003-1321-6866Papers by this author
worksAn Atypical Presentation of Diabetic Myonecrosis
2018 · AACE Clinical Case Reports · 6 citations
https://doi.org/10.4158/accr-2018-0228
First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry
2020 · Thrombosis Update · 3 citations
https://doi.org/10.1016/j.tru.2020.100010
Platypnea-Orthodeoxia Syndrome and COVID-19 Successfully Treated With Percutaneous Patent Foramen Ovale Closure: A Report of Two Cases and Literature Review
2024 · Cureus · 0 citations
https://doi.org/10.7759/cureus.56655
Direct oral anticoagulants versus vitamin K antagonists in patients with thrombotic antiphospholipid syndrome: A prospective observational analysis
2024 · Medicina Clínica · 0 citations
https://doi.org/10.1016/j.medcli.2024.10.020
Impact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry
2025 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-025-90278-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat